GOGary David Osborn

Gary David Osborn

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Gary David Osborn has a total of 9 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Is primary endocrine therapy effective in treating the elderly, unfit patient with breast cancer?

    by G Osborn, M Jones, C Champ, K Gower-Thomas, E Vaughan-Williams

    INTRODUCTION: Elderly patients with oestrogen receptor (ER)-positive breast cancer wishing to avoid surgery or those who are considered unsuitable for a general anaesthetic may be treated with primary endocrine therapy. We have reviewed all patients with ER-positive breast cancer who were initially treated with primary hormone therapy (PHT) at a district general hospital in south Wales and investigated their outcome in order to evaluate the appropriateness of this method of managing breast cancer. MATERIALS AND METHODS: All patients with breast cancer who were initially treated with PHT between January 2002 and December 2008 were identified from a single consultant's prospectively maintained database. For each patient the Charlson co-morbidity index was calculated to give an estimate of ten-year survival. Patients who had died during the study period were identified from hospital and cancer registries. RESULTS: A total of 83 cancers in 82 patients with a median age of 81 years (range: 62–93 years) were included. All cancers were ER-positive. Six patients (7%) had a greater than 50% chance of surviving ten years, calculated using the Charlson index. The median follow-up period was 24 months (range: 6–72 months). Twelve patients (15%) had disease progression while taking PHT. Twenty-three patients (28%) have died (median time from diagnosis to death of 10.5 months, range: 1–77 months). Two patients (2%) experienced disease progression within six months of starting PHT and the number of patients whose cancer progressed increased with increasing length of follow up. Fourteen patients (17%) eventually underwent a wide local excision under local anaesthetic. CONCLUSIONS: PHT can be considered an effective treatment in this elderly, unfit population with the aim of stopping disease progression so that these patients die with their breast cancer, not of it.


  • A review of needle core biopsy diagnosed radial scars in the Welsh Breast Screening Programme

    by G Osborn, F Wilton, G Stevens, E Vaughan-Williams, K Gower-Thomas

    INTRODUCTION: Radial scars are benign breast lesions; their appearance on mammography may, however, mimic carcinoma. Needle core biopsy is performed for pre-operative diagnosis and, currently in Wales, all lesions with benign biopsy results are surgically excised. We have reviewed all cases of needle core biopsy-diagnosed radial scars from the Welsh breast screening programme, Breast Test Wales (BTW), and investigated the outcome of radial scars based on histology from surgical excision in order to evaluate the appropriateness of the current management of these lesions in Wales. PATIENTS AND METHODS: All needle core biopsy diagnosed radial scars were identified from the BTW screening database from the start of screening in 1989 until the end of 2007. RESULTS: A total of 118 patients were diagnosed with radial scars on needle core biopsy; two patients had bilateral radial scars. Median patient age was 54 years (range, 49-68 years). Ninety-five lesions (79%) were thought to be pure radial scars on needle core biopsy; however, only 81 pure radial scars were identified on excision biopsy histology. Carcinoma was present in seven patients and ductal carcinoma in situ in nine patients at excision biopsy. In two patients, the cancers occurred in lesions reported as pure radial scars on needle core biopsy. Twenty-two lesions showed atypical ductal or lobular hyperplasia (ADH/ALH) or both on excision biopsy; 14 of these lesions were classed as pure radial scars by needle core biopsy. CONCLUSIONS: All core biopsy diagnosed radial scars, presenting as screen detected abnormalities, should be excised due to their association with premalignant and malignant conditions.


  • Breast disease diagnostic ability of nurse practitioners and surgeons

    by Gary David Osborn, Maria Jones, Kate Gower‐Thomas, Eifion Vaughan‐Williams

    Osborn g.d., jones m., gower‐thomas k. & vaughan‐williams e. (2010) Breast disease diagnostic ability of nurse practitioners and surgeons. Journal of Advanced Nursing 66(7), 1452–1458. Title.  Breast disease diagnostic ability of nurse practitioners and surgeons. Aim.  This paper is a report of a study to compare history‐taking and breast and axillary examination skills of nurse practitioners and surgeons.Background.  In the United Kingdom, patients referred by their general practitioners with suspected breast cancer should be seen within 2 weeks by a specialist. As a result of the European Working Time Directive there has been a reduction in junior doctors’ working hours within the European Union. This makes such targets harder to achieve and risks delays in patient assessment and diagnosis. Trained nurse practitioners can perform an important role in assessing new patients in breast clinics to ensure that they are seen expeditiously. Nurse practitioners’ competence assessing patients with breast disease needs to be objectively demonstrated.Methods.  Between 1st March 2007 and 31st March 2008 patients referred to a symptomatic breast disease clinic were seen by a single nurse practitioner and a single consultant surgeon. Findings were recorded on a standardised pro forma and compared using one‐way analysis of variance.Findings.  Assessments were recorded for 128 patients. No abnormality was found in 41% of patients but nine (7%) had breast cancer. There was no evidence of a statistically significant mismatch in scoring between the nurse practitioner and consultant surgeon. Thirty‐seven lumps were identified in 35 patients. There was no difference in mammography requests from the nurse practitioner and surgeon.Conclusion.  The diagnostic accuracy of a nurse practitioner compares favourably with that of a consultant surgeon.